Product
Modified FOLFIRINOX
1 clinical trial
1 indication
Indication
Stage III Pancreatic CancerClinical trial
A Randomized, Multicenter, Controlled, Unblinded Study to Assess the Safety and Efficacy of the NanoKnife® System for the Ablation of Unresectable Stage 3 Pancreatic AdenocarcinomaStatus: Recruiting, Estimated PCD: 2023-12-01